NCT02850276View on ClinicalTrials.gov

Autonomic Neuropathy, GI Motility, and Inflammation in HIV

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 1, 2018

Study Completion Date

June 1, 2018

Conditions
HIV Disease
Interventions
DRUG

Pyridostigmine

Trial Locations (1)

10029

Icahn School of Medicine at Mount Sinai, New York

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02850276 - Autonomic Neuropathy, GI Motility, and Inflammation in HIV | Biotech Hunter | Biotech Hunter